National Bureau of Economic Research
NBER: Fw: NIH Funding opps: Alchohol & Chronic Disease

Fw: NIH Funding opps: Alchohol & Chronic Disease

From: Janet Stein <jbstein_at_nber.org>
Date: Tue, 16 Jul 2013 13:47:58 +0000

To: Members of NBER Aging, Health Care, Health Economics and Childrens
Programs.

NIAAA has issued new R03, R21 and R01 funding opportunities on
"Secondary Analyses of Alcohol and Chronic Disease." Proposals are due
on the standard dates (next up are: October 5 for R01; and October 16
for R03 and R21). No letter of intent is requested.

Secondary Analyses of Alcohol and Chronic Disease
R01: http://grants.nih.gov/grants/guide/pa-files/PA-13-260.html
R21: http://grants.nih.gov/grants/guide/pa-files/PA-13-251.html
R03: http://grants.nih.gov/grants/guide/pa-files/PA-13-261.html
These funding opportunities encourage use of existing datasets to
examine associations between alcohol and chronic disease. Alcohol
consumption has a significant effect on chronic disease from the
probable benefits of moderate drinking to the detrimental effects of
heavy drinking. Research is needed to better understand the impact of
alcohol on chronic disease and the myriad factors that may interact with
alcohol to modify chronic disease risk.

Alcohol-related chronic diseases and conditions of interest include, but
are not limited to: Alzheimer's disease, cardiovascular disease, cancer,
chronic liver disease, chronic pancreatitis, type 2 diabetes, fetal
alcohol syndrome, HIV/AIDS, hypertension, age-related macular
degeneration, metabolic syndrome, obesity, osteoporosis, and psychiatric
disorders such as depression and schizophrenia. Healthy aging and
survival free of chronic disease are included.

This funding opportunity does not exclude any secondary analyses that
use epidemiologic or clinical data to study associations between alcohol
and chronic disease (including biomarkers/intermediate outcomes). Of
particular interest is the examination of understudied areas,
populations, exposures, or outcomes. A significant barrier to conducting
secondary data analyses on alcohol and chronic disease is that many
epidemiologic or clinical studies have too few subjects to examine
critical subgroups, rare exposures, or rare outcomes. Secondary analyses
of existing datasets may overcome that barrier in a cost-efficient
manner through use of combined or pooled datasets, or targeted
sub-studies within ongoing cohorts. To facilitate secondary analyses of
understudied areas up to 25% of the direct costs of the grant may be
spent on acquiring new information that would significantly strengthen
the analysis. Such information may, for example, be derived from
re-contacting subjects, or laboratory testing of stored specimens.
Obtaining such new information must serve the purpose of the secondary
data analysis and should not be considered for any other reason.

Check the full announcements for details.

Please feel free to contact us if you are interested in this
competition, to discuss which type of grant might be best, or in
learning more about NIH proposals and grants generally. We look forward
to working with you.

Janet

Janet Stein
Program Administrator
National Bureau of Economic Research
1050 Massachusetts Avenue
Cambridge, MA 02138

phone: (617) 588-0366
fax: (617) 868-2742
Received on Tue Jul 16 2013 - 09:47:58 EDT